Estelle J A Suys (Estelle Ja Suys)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Recombinant Human

Sentinel Lymph Node

Top Venues

Molecular pharmaceutics

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Hs Brundel, Orlagh M Feeney, Cameron J Nowell, Estelle J A Suys, Gracia Gracia, Lisa M Kaminskas, Michelle M McIntosh, David W Kang, Christopher J H Porter
Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration. Nanomedicine (London, England) 16 (4) (2021)
Yusuke Tanaka, Tri-Hung Nguyen, Estelle J A Suys, Christopher J H Porter
Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability. Molecular pharmaceutics 18 (4) (2021)
Thai Thanh Hoang Thi, Estelle J A Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park, Nghia Phuoc Truong
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines 9 (4) (2021)
Danijela Zukancic, Estelle J A Suys, Emily H Pilkington, Azizah Algarni, Hareth A Al-Wassiti, Nghia Phuoc Truong
The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles. Pharmaceutics 12 (11) (2020)
Estelle J A Suys, David K Chalmers, Colin W Pouton, Christopher J H Porter
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation. Molecular pharmaceutics 15 (6) (2018)